Exozymes EXOZ
NASDAQ EXOZ
$7.04 +0.64 (+10.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Exozymes (EXOZ) EBIT (2023 - 2026)

Exozymes (EXOZ) posted quarterly EBIT of -$2.7 million for Q4 2025, down 35.91% year-over-year from -$4.2 million in Q4 2024, and down 6.87% quarter-over-quarter from -$2.5 million in Q3 2025.

Exozymes (EXOZ) EBIT (2023 - 2026) Analysis & Trends

Exozymes (EXOZ) has reported EBIT for 3 consecutive years, with -$2.7 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, EBIT fell 35.91% year-over-year to -$2.7 million; the TTM figure through Dec 2025 stood at -$9.7 million (down 63.79% YoY), while the FY2025 annual figure was -$9.7 million, down 63.79% from the prior year.
  • EBIT fell to -$2.7 million in Q4 2025 per EXOZ's latest filing, from -$2.5 million in the prior quarter.
  • Across five years, EBIT topped out at -$391846.0 in Q3 2023 and bottomed at -$2.7 million in Q4 2025.
  • Historically, EBIT has averaged -$1.7 million across 3 years, with a median of -$1.8 million in 2024.
  • Annual changes were most pronounced in 2024 — EBIT plunged 311.32% — and 2025, when it slumped 35.91%.
  • Exozymes' EBIT stood at -$985047.0 in 2023, then plunged by 101.34% to -$2.0 million in 2024, then tumbled by 35.91% to -$2.7 million in 2025.
  • Business Quant data shows EXOZ's EBIT at -$2.7 million in Q4 2025, -$2.5 million in Q3 2025, and -$2.5 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 1.25 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 1.29 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 493.00 Mn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -815.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 325.05 Mn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 231.44 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -1.55 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 133.12 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn -375.75 Mn
10 Exozymes 61.53 Mn 61.53 Mn - -2.95 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.95 Mn
Dec 31, 2025 -2.70 Mn
Sep 30, 2025 -2.52 Mn
Jun 30, 2025 -2.55 Mn
Mar 31, 2025 -1.95 Mn
Dec 31, 2024 -1.98 Mn
Sep 30, 2024 -1.61 Mn
Jun 30, 2024 -1.33 Mn
Mar 31, 2024 -1.01 Mn
Dec 31, 2023 -985,047.00
Sep 30, 2023 -391,846.00